Drug intelligence / Profile preview

wen-yang-shu-gan decoction

Development stage: Preclinical
Lead developer: Zhongda Hospital, Southeast University
Administration: Oral

Overview

Wen-Yang-Shu-Gan decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by Zhongda Hospital, Affiliated to Southeast University. It is specifically indicated for the treatment of insomnia associated with the TCM syndrome of 'yang deficiency and liver depression.' The decoction is intended to restore physiological balance by warming the body's yang energy and relieving liver qi stagnation, which are believed to be the root causes of sleep disturbances in this patient population. It is currently undergoing clinical evaluation to assess its therapeutic efficacy and safety.

Other names: Wen-Yang-Shu-Gan decoction

Targets

YY1 (Yin Yang 1 transcription factor)

Beyond the preview

Go deeper on wen-yang-shu-gan decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on wen-yang-shu-gan decoction.

Explore the full profile